Lincoln Pharmaceuticals Share Price
₹737.75 -32.45 (-4.21%)
22 Jan, 2025 12:37
Start SIP in LINCOLN
Start SIPPerformance
- Low
- ₹733
- High
- ₹774
- 52 Week Low
- ₹535
- 52 Week High
- ₹980
- Open Price₹770
- Previous Close₹770
- Volume19,555
Investment Returns
- Over 1 Month -9.16%
- Over 3 Month + 11.64%
- Over 6 Month + 17.33%
- Over 1 Year + 11.19%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 15.3
- PEG Ratio
- 0.8
- Market Cap Cr
- 1,478
- P/B Ratio
- 2.3
- Average True Range
- 39.9
- EPS
- 48.25
- Dividend Yield
- 0.2
- MACD Signal
- 1.8
- RSI
- 43.8
- MFI
- 61.32
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹737.75
-32.45
(-4.21%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹801.98
- 50 Day
- ₹783.21
- 100 Day
- ₹746.88
- 200 Day
- ₹697.57
Resistance and Support
780.93
- R3 839.47
- R2 823.53
- R1 796.87
- S1 754.27
- S2 738.33
- S3 711.67
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend | |
2024-02-08 | Quarterly Results | |
2023-11-02 | Quarterly Results |
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹737 As on 22 January, 2025 | 12:23
The Market Cap of Lincoln Pharmaceuticals is ₹1477.7 Cr As on 22 January, 2025 | 12:23
The P/E ratio of Lincoln Pharmaceuticals is 15.3 As on 22 January, 2025 | 12:23
The PB ratio of Lincoln Pharmaceuticals is 2.3 As on 22 January, 2025 | 12:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.